Pharma Journalist - Page 836 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Bayer’s BAY94-9027 Biologics License Application accepted by U.S. FDA

Daiichi Sankyo’s ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in TGCT

Novartis submits application to FDA for Kymriah (tisagenlecleucel)

Saudi FDA approves Sobi’s Alprolix for the treatment of haemophilia B

AbbVie receives FDA Priority Review for elagolix

Charles River Announces Expansion of In Vitro Oncology Services

Zydus receives final approval from the USFDA for Tamoxifen Citrate Tablets USP

Lannett and Celgene enter into settlement and License Agreement related to Thalomid

Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim’s BI 882370

New to 2018: The Role of Artificial Intelligence in Drug Discovery